Yang, Yu ChiBanuelos, Carmen AdrianaMawji, Nasrin RWang, JunKato, MinoruHaile, SimonMcEwan, Iain JPlymate, StephenSadar, Marianne D2017-05-022017-05-022016-09-01Yang, Y C, Banuelos, C A, Mawji, N R, Wang, J, Kato, M, Haile, S, McEwan, I J, Plymate, S & Sadar, M D 2016, 'Targeting androgen receptor activation function-1 with EPI to overcome resistance mechanisms in castration-resistant prostate cancer', Clinical Cancer Research, vol. 22, no. 17, pp. 4466–4477. https://doi.org/10.1158/1078-0432.CCR-15-29011078-0432http://hdl.handle.net/2164/8599Acknowledgments The authors thank Kate Watt (University of Aberdeen, Aberdeen, Scotland) for technical support. The authors are also grateful to Country Meadows Senior Men's Golf Charity Classic for financial support of this research. Financial support: This research was supported by grants to MDS from the NCI (2R01CA105304), the Canadian Institutes of Health Research (MOP79308) and the US Army Medical Research and Materiel Command Prostate Cancer Research Program (E81XWH-11-1-0551). Research by IJM’s group was supported by the Chief Scientist’s Office of the Scottish Government (ETM-258 and -382). We are grateful to Country Meadows Senior Men’s Golf Charity Classic for financial support of this research.1215588811engSDG 3 - Good Health and Well-beingandrogen receptorN-terminal domainEPIcastration-resistant prostate cancerresistance mechanismsRC0254 Neoplasms. Tumors. Oncology (including Cancer)Chief Scientist Office (CSO)ETM-258ETM-382Supplementary DataRC0254Targeting androgen receptor activation function-1 with EPI to overcome resistance mechanisms in castration-resistant prostate cancerJournal article10.1158/1078-0432.CCR-15-29012217